"10.1371_journal.pone.0097847","plos one","2014-05-19T00:00:00Z","Alessandra De Robertis; Federica Mennillo; Marco Rossi; Silvia Valensin; Patrizia Tunici; Elisa Mori; Nicola Caradonna; Maurizio Varrone; Massimiliano Salerno","Molecular Oncology Unit, Siena Biotech Medicine Research Centre, Siena, Italy; Department of Pharmacology, Siena Biotech Medicine Research Centre, Siena, Italy; In Vivo Pharmacology Unit, Siena Biotech Medicine Research Centre, Siena, Italy; Data Analysis Unit, Siena Biotech Medicine Research Centre, Siena, Italy; MET Profiling Unit, Siena Biotech Medicine Research Centre, Siena, Italy; Department of Medicinal Chemistry, Siena Biotech Medicine Research Centre, Siena, Italy","Â¶ These authors also contributed equally to this work","We have the following interests. All authors are employed by the Siena Biotech Medicine Research Centre. The molecules reported in the manuscript (SEN461 and the inactive analogue SEN973) are both covered by patent application (WO/2011/042145), inventors: Massimiliano Salerno and Maurizio Varrone. There are no further patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2014","05","Alessandra De Robertis","ADR",9,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
